IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway
Medical Principles and Practice · 2024 · 33 (3) · 269-280
DOI: 10.1159/000538467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Principles and Practice, online erschienen am 02.04.2024. Verfasst von Shenglong Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Provincial People's Hospital, Department II of Neurology, Xi'an, China. Hauptthemen laut MEDLINE: Hedgehog Proteins, Apoptosis, Insulin-Like Growth Factor Binding Protein 5, Oxidopamine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Parkinson’s disease (PD) is the most common neurodegenerative disease worldwide. Studies have shown that insulin-like growth factor-binding protein 5 (IGFBP5) may contribute to methamphetamine-induced neurotoxicity and neuronal apoptosis in PC-12 cells and rat striatum. Here, we studied the expression and role of IGFBP5 in the 6-OHDA-toxicant model of PD.
Methods
PC-12 and SH-SY5Y cells were exposed to 50 μm 6-OHDA for 24 h. qRT-PCR, western blotting, CCK-8 assay, EdU staining, annexin V staining, and immunofluorescence were performed to study the effects of IGFBP5-specific siRNAs. The effects of IGFBP5 on a rat 6-OHDA model of PD were confirmed by performing behavioral tests, tyrosine hydroxylase (TH) immunofluorescence staining, and western blotting.
Results
In the GSE7621 dataset, IGFBP5 was highly expressed in the substantia nigra tissues of PD patients compared to healthy controls. In PC-12 and SH-SY5Y cells, IGFBP5 was upregulated following 6-OHDA exposure in a dose-dependent manner. Silencing of IGFBP5 promoted PC-12 and SH-SY5Y proliferation and inhibited apoptosis under 6-OHDA stimulation. Silencing of IGFBP5 relieved 6-OHDA-induced TH-positive neuron loss. Hedgehog signaling pathway was predicted as a downstream signaling pathway of IGFBP5. Negative regulation between IGFBP5 and sonic hedgehog (SHH) signaling pathway was confirmed in vitro. The effects of IGFBP5 silencing on SH-SY5Y cells were partially reversed using cyclopamine, a direct inhibitor of the SHH signaling pathway. In addition, silencing of IGFBP5 attenuated motor deficits and neuronal damage in 6-OHDA-induced PD rats.
Conclusion
Elevated IGFBP5 expression may be involved in 6-OHDA-induced neurotoxicity through regulation of the SHH signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shaanxi Provincial People's Hospital, Department II of Neurology, Xi'an, China.
Zitieren
APA
Guo, S., Lei, Q., Yang, Q., & Chen, R. (2024). IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway. Medical Principles and Practice, 33(3), 269-280. https://doi.org/10.1159/000538467
Vancouver
Guo S, Lei Q, Yang Q, Chen R. IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway. Medical Principles and Practice. 2024;33(3):269-280. doi:10.1159/000538467
BibTeX
@article{Guo2024,
author = {Guo, Shenglong and Lei, Qi and Yang, Qian and Chen, Ruili},
title = {IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson’s Disease by Inhibiting the Sonic Hedgehog Signaling Pathway},
journal = {Medical Principles and Practice},
year = {2024},
volume = {33},
number = {3},
pages = {269--280},
doi = {10.1159/000538467}
}
EUVIMED